The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan

The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan

The journey to implement cancer genomic medicine (CGM) in oncology practice began in the 1980s, which is considered the dawn of genetic and genomic cancer research. At the time, a variety of activating oncogenic alterations and their functional significance were unveiled in cancer cells, which led t...

Full description

Bibliographic Details
Main Authors: Teruhiko Yoshida, Yasushi Yatabe, Ken Kato, Genichiro Ishii, Akinobu Hamada, Hiroyuki Mano, Kuniko Sunami, Noboru Yamamoto, Takashi Kohno
Format: Article
Language:English
Published: China Anti-Cancer Association 2024-01-01
Series:Cancer Biology & Medicine
Subjects:
cancer genomic medicine
biobank
patient-derived xenograft
multi-gene panel test
whole genome sequencing
Online Access:https://www.cancerbiomed.org/content/21/1/29

Internet

https://www.cancerbiomed.org/content/21/1/29

Similar Items